FARRAH GARDNER: Open Payments
NPI 1477915569 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 17 payments from 7 companies in 2025. Trend: 2023 $497 · 2024 $538 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $146 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: TRELEGY ELLIPTA, LEQVIO, BREZTRI, CAPLYTA, EVENITY, Cologuard Collection Kit, VRAYLAR.
Industry payments across GA — which companies pay providers there.
